22-29260795-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000216085.12(RHBDD3):āc.602T>Cā(p.Leu201Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000187 in 1,601,122 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000216085.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RHBDD3 | NM_012265.3 | c.602T>C | p.Leu201Ser | missense_variant | 5/7 | ENST00000216085.12 | NP_036397.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHBDD3 | ENST00000216085.12 | c.602T>C | p.Leu201Ser | missense_variant | 5/7 | 1 | NM_012265.3 | ENSP00000216085 | P1 | |
RHBDD3 | ENST00000496342.1 | n.641T>C | non_coding_transcript_exon_variant | 2/3 | 2 | |||||
RHBDD3 | ENST00000413137.6 | c.*178T>C | 3_prime_UTR_variant, NMD_transcript_variant | 5/7 | 5 | ENSP00000399550 | ||||
RHBDD3 | ENST00000414672.5 | downstream_gene_variant | 5 | ENSP00000413128 |
Frequencies
GnomAD3 genomes AF: 0.0000133 AC: 2AN: 149924Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000857 AC: 2AN: 233346Hom.: 0 AF XY: 0.00000785 AC XY: 1AN XY: 127436
GnomAD4 exome AF: 6.89e-7 AC: 1AN: 1451198Hom.: 0 Cov.: 32 AF XY: 0.00000139 AC XY: 1AN XY: 721442
GnomAD4 genome AF: 0.0000133 AC: 2AN: 149924Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 73242
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 21, 2021 | The c.602T>C (p.L201S) alteration is located in exon 5 (coding exon 3) of the RHBDD3 gene. This alteration results from a T to C substitution at nucleotide position 602, causing the leucine (L) at amino acid position 201 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at